Similarly, Plasminogen Activator Inhibitor-1 (PAI-1) was found as an independent risk factor for obesity-related metabolic disorders, even though it needs further investigation on mechanisms of action [53]. This evidence concerns the gene SERPINE1 and metabolic disease.